FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Greenberg Robert J.
   2. Issuer Name and Ticker or Trading Symbol
SECOND SIGHT MEDICAL PRODUCTS INC [EYES] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
(Last)
(First)
(Middle)
12744 SAN FERNANDO ROAD, BUILDING 3		 3. Date of Earliest Transaction (Month/Day/Year)
01/01/2015
(Street)

SYLMAR, CA 91342		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/01/2015   M   59,063 (1) A $ 4.75 363,063 D  
Common Stock 01/01/2015   F   27,344 (2) D $ 10.26 (3) 335,719 D  
Common Stock 01/01/2015   F   12,055 (4) D $ 10.26 (3) 323,664 (5) D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option(b) $ 4.25               (6) 01/01/2017 Common Stock 125,000   125,000 D  
Option(c) $ 4.75               (6) 09/01/2015 Common Stock 150,000   150,000 D  
Option(d) $ 4.75               (6) 01/01/2016 Common Stock 17,969   17,969 D  
Option(e) $ 5               (6) 05/01/2016 Common Stock 8,223   8,223 D  
Option(f) $ 5               (6) 01/01/2017 Common Stock 30,265   30,265 D  
Option(g) $ 5               (6) 02/01/2018 Common Stock 23,750   23,750 D  
Option(h) $ 5               (6) 11/01/2018 Common Stock 150,000   150,000 D  
Option(i) $ 5               (6) 02/01/2019 Common Stock 33,750   33,750 D  
Option(j) $ 5               (6) 02/01/2020 Common Stock 53,125   53,125 D  
Option(k) $ 5               (6) 02/01/2020 Common Stock 50,625   50,625 D  
Option(l) $ 5               (7) 03/01/2021 Common Stock 41,563 (7)   41,563 D  
Option(m) $ 5               (8) 03/01/2022 Common Stock 29,063 (8)   29,063 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Greenberg Robert J.
12744 SAN FERNANDO ROAD, BUILDING 3
SYLMAR, CA 91342		   X     Chief Executive Officer  

Signatures

 /s/ Robert J. Greenberg   01/05/2015
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Dr. Greenberg exercised 59,063 vested options (which otherwise would have expired on January 1, 2015) reported as Option(2) on Form 3 filed with the SEC on November 18, 2014.
(2) Dr. Greenberg tendered 27,344 shares of common stock to the Company in accordance with Rule 16b-3.
(3) The fair market value on the day of the exercise.
(4) The Company withheld 12,055 shares to cover taxes.
(5) After giving effect to (i) exercise of 59,063 options, (ii) tendering to the Company 27,344 shares for the exercise of 59,063 options, and (iii) withholding by Company of 12,055 shares to cover taxes, Dr. Greenberg acquired net 19,664 shares.
(6) These are vested employee options currently exercisable.
(7) Includes 31,172 options currently exercisable and 10,391 options that will vest and become exercisable in the next 60 days.
(8) Includes 19,375 options currently exercisable and 9,688 options that will vest and become exercisable in the next 60 days.
 
Remarks:
Excludes unvested employee options in amount of 471,221 shares, not exercisable for over 60 days from this date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.